Application of Machine Learning for Tumor Growth Inhibition – Overall Survival Modeling Platform

17Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Machine learning (ML) was used to leverage tumor growth inhibition (TGI) metrics to characterize the relationship with overall survival (OS) as a novel approach and to compare with traditional TGI-OS modeling methods. Historical dataset from a phase III non-small cell lung cancer study (OAK, atezolizumab vs. docetaxel, N = 668) was used. ML methods support the validity of TGI metrics in predicting OS. With lasso, the best model with TGI metrics outperforms the best model without TGI metrics. Boosting was the best linear ML method for this dataset with reduced estimation bias and lowest Brier score, suggesting better prediction accuracy. Random forest did not outperform linear ML methods despite hyperparameter optimization. Kernel machine was marginally the best nonlinear ML method for this dataset and uncovered nonlinear and interaction effects. Nonlinear ML may improve prediction by capturing nonlinear effects and covariate interactions, but its predictive performance and value need further evaluation with larger datasets.

Cite

CITATION STYLE

APA

Chan, P., Zhou, X., Wang, N., Liu, Q., Bruno, R., & Jin, J. Y. (2021). Application of Machine Learning for Tumor Growth Inhibition – Overall Survival Modeling Platform. CPT: Pharmacometrics and Systems Pharmacology, 10(1), 59–66. https://doi.org/10.1002/psp4.12576

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free